
Emutaz 1.125gm Injection
Marketer
Mediwood Healthcare Pvt Ltd
Salt Composition
Ceftazidime (1000mg) + Tazobactum (125mg)
Overview Emutaz 1.125gm Injection
Combiflox 1.125g Injection, a multi-component medication, combats diverse bacterial infections. Its action inhibits microbial proliferation, curbing infection spread. Administration must be solely under a doctor's direction; strict adherence to the prescribed schedule is crucial. Complete the full course, regardless of symptom improvement; premature cessation may reduce efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia. Worsening side effects necessitate immediate medical attention. Allergic reactions (rash, itching, edema, dyspnea) require prompt emergency care. Inform your physician of all concurrent medications, including those for pre-existing conditions. Pregnant or lactating individuals require prior medical consultation. Alcohol consumption should be avoided due to potential increased drowsiness. While typically non-impairing to driving ability, drowsiness or dizziness mandates driving cessation. Adequate rest, balanced nutrition, and ample hydration contribute to faster recovery. Your doctor may order laboratory and diagnostic tests to monitor the medication's impact.
Primary Ingredients of Emutaz 1.125gm Injection
No text provided. Please provide the text you want me to rephrase.
Uses of Emutaz 1.125gm Injection
Infections caused by bacteria
Major Benefits of Emutaz 1.125gm Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Emutaz 1.125gm Injection:
- Nausea
- Vomiting
- Diarrhea
- Stomach pain
- Increased liver enzymes
- Allergic reaction
How to use Emutaz 1.125gm Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Emutaz 1.125gm Injection works:
Emutaz 1.125gm Injection combines Ceftazidime, a cell-wall synthesis inhibitor antibiotic, with Tazobactum, a beta-lactamase inhibitor. Ceftazidime's mechanism involves disrupting bacterial cell wall formation, crucial for bacterial viability. Tazobactum counters bacterial resistance mechanisms, thereby boosting Ceftazidime's antibacterial effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with concurrent use of Emutaz 1.125gm Injection and alcohol.
PregnancySAFE IF PRESCRIBED
The injectable formulation of Emutaz (1.125 gm) is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no negative consequences for fetal development; nonetheless, data from human trials remain scarce.
Breast feedingSAFE IF PRESCRIBED
The injectable medication Emutaz, 1.125gm, presents no known breastfeeding contraindications. Research in humans indicates minimal drug transfer to breast milk, posing negligible risk to the infant.
DrivingUNSAFE
Administering Emutaz 1.125gm Injection may induce drowsiness, blurred vision, and dizziness. Driving should be avoided if these effects are experienced.
KidneyCAUTION
The use of Emutaz 1.125gm Injection requires careful consideration in individuals with impaired kidney function. A modified dosage of Emutaz 1.125gm Injection might be necessary. Physician consultation is advised.
LiverCAUTION
For patients with significant hepatic impairment, administration of the 1.125-gram Emutaz injection requires careful monitoring. Dosage modification of the 1.125-gram Emutaz injection may be necessary. Physician consultation is advised.
What if you forget to take Emutaz 1.125gm Injection :
Should you forget a scheduled Emutaz 1.125gm Injection, seek medical advice.
Facts to Know About Emutaz 1.125gm Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Antimicrobials |
